BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 14742744)

  • 1. Extracellular signal-regulated kinase/mitogen-activated protein kinases block internalization of delta-opioid receptors.
    Eisinger DA; Schulz R
    J Pharmacol Exp Ther; 2004 May; 309(2):776-85. PubMed ID: 14742744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta-opioid receptors activate ERK/MAP kinase via integrin-stimulated receptor tyrosine kinases.
    Eisinger DA; Ammer H
    Cell Signal; 2008 Dec; 20(12):2324-31. PubMed ID: 18804531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic morphine treatment inhibits opioid receptor desensitization and internalization.
    Eisinger DA; Ammer H; Schulz R
    J Neurosci; 2002 Dec; 22(23):10192-200. PubMed ID: 12451120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of c-Cbl by morphine accounts for persistent ERK1/2 signaling in delta-opioid receptor-expressing HEK293 cells.
    Eisinger DA; Ammer H
    J Biol Chem; 2009 Dec; 284(50):34819-28. PubMed ID: 19828455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidermal growth factor treatment switches δ-opioid receptor-stimulated extracellular signal-regulated kinases 1 and 2 signaling from an epidermal growth factor to an insulin-like growth factor-1 receptor-dependent mechanism.
    Eisinger DA; Ammer H
    Mol Pharmacol; 2011 Feb; 79(2):326-35. PubMed ID: 21078885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delta opioid receptors expressed by stably transfected jurkat cells signal through the map kinase pathway in a ras-independent manner.
    Shahabi NA; Daaka Y; McAllen K; Sharp BM
    J Neuroimmunol; 1999 Feb; 94(1-2):48-57. PubMed ID: 10376935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. mu and delta-opioid receptor agonists induce mitogen-activated protein kinase (MAPK) activation in the absence of receptor internalization.
    Kramer HK; Simon EJ
    Neuropharmacology; 2000 Jul; 39(10):1707-19. PubMed ID: 10884553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid control of MAP kinase cascade.
    Schulz R; Eisinger DA; Wehmeyer A
    Eur J Pharmacol; 2004 Oct; 500(1-3):487-97. PubMed ID: 15464054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosducin, beta-arrestin and opioid receptor migration.
    Schulz R; Wehmeyer A; Murphy J; Schulz K
    Eur J Pharmacol; 1999 Jun; 375(1-3):349-57. PubMed ID: 10443588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of EGF-induced ERK/MAP kinase-mediated astrocyte proliferation by mu opioids: integration of G protein and beta-arrestin 2-dependent pathways.
    Miyatake M; Rubinstein TJ; McLennan GP; Belcheva MM; Coscia CJ
    J Neurochem; 2009 Jul; 110(2):662-74. PubMed ID: 19457093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-endocytic fates of delta-opioid receptor are regulated by GRK2-mediated receptor phosphorylation and distinct beta-arrestin isoforms.
    Zhang X; Wang F; Chen X; Chen Y; Ma L
    J Neurochem; 2008 Jul; 106(2):781-92. PubMed ID: 18419762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism and consequences of delta-opioid receptor internalization.
    Eisinger DA; Schulz R
    Crit Rev Neurobiol; 2005; 17(1):1-26. PubMed ID: 16307525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The three α1-adrenoceptor subtypes show different spatio-temporal mechanisms of internalization and ERK1/2 phosphorylation.
    Perez-Aso M; Segura V; Montó F; Barettino D; Noguera MA; Milligan G; D'Ocon P
    Biochim Biophys Acta; 2013 Oct; 1833(10):2322-33. PubMed ID: 23797059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of extracellular signal-regulated kinase (ERK) by opioid and cannabinoid receptors that are expressed in the same cell.
    Korzh A; Keren O; Gafni M; Bar-Josef H; Sarne Y
    Brain Res; 2008 Jan; 1189():23-32. PubMed ID: 18068691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of mitogen-activated protein kinase in agonist-induced phosphorylation of the mu-opioid receptor in HEK 293 cells.
    Schmidt H; Schulz S; Klutzny M; Koch T; Händel M; Höllt V
    J Neurochem; 2000 Jan; 74(1):414-22. PubMed ID: 10617147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delta opioid activation of the mitogen-activated protein kinase cascade does not require transphosphorylation of receptor tyrosine kinases.
    Kramer HK; Onoprishvili I; Andria ML; Hanna K; Sheinkman K; Haddad LB; Simon EJ
    BMC Pharmacol; 2002; 2():5. PubMed ID: 11897012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-specific regulation of delta-opioid receptor trafficking by G protein-coupled receptor kinase and beta-arrestin.
    Zhang J; Ferguson SS; Law PY; Barak LS; Caron MG
    J Recept Signal Transduct Res; 1999; 19(1-4):301-13. PubMed ID: 10071766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor.
    Nowoczyn M; Marie N; Coulbault L; Hervault M; Davis A; Hanouz JL; Allouche S
    Neuropharmacology; 2013 Oct; 73():368-79. PubMed ID: 23792280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opioid receptor endocytosis and activation of MAP kinase pathway.
    Trapaidze N; Gomes I; Cvejic S; Bansinath M; Devi LA
    Brain Res Mol Brain Res; 2000 Mar; 76(2):220-8. PubMed ID: 10762697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agonist-induced internalization and mitogen-activated protein kinase activation of the human prostaglandin EP4 receptor.
    Desai S; Ashby B
    FEBS Lett; 2001 Jul; 501(2-3):156-60. PubMed ID: 11470276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.